BOSTON and LUND, Sweden, November 28, 2014 /PRNewswire/ --
Northeastern University and Phase Holographic Imaging (PHI) today announced a collaboration agreement. The agreement extends the ongoing PHI's HoloMonitor® technology evaluation program at Northeastern to create a Holographic Imaging Cytometry Program of Excellence - an application development hub and educational resource providing training programs for scientists using time-lapse cytometry.
PHI's HoloMonitor technology enables analysis of label-free cellular specimens utilizing the principles of holography. Unlike conventional microscopy, it permits measurement of quantitative parameters, such as cell thickness and volume. Digital focusing techniques enable fully automated time-lapse image acquisition. The incubator-tolerant design and the use of a low-power light source make HoloMonitor technology especially well-suited for long-term kinetic analysis. Proprietary software permits effortless cell tracking and quantitative feature analysis.
Under the agreement, PHI will provide Northeastern with instrumentation for the purpose of establishing novel cell analysis applications based on HoloMonitor technology. Northeastern will develop and publish research applications, offer feedback and help guide future technology developments. Northeastern will also serve as a reference site and create a Holographic Imaging Cytometry Program of Excellence.
"The initial evaluation produced an overwhelming amount of data to support the importance of HoloMonitor technology for research programs within the Department of Pharmaceutical Sciences. We intend to bring the benefits of PHI technology to academic and industrial institutions in the Boston area by offering access to our core facility and our expertise", said Mansoor Amiji, Distinguished Professor and Chair of the Department of Pharmaceutical Sciences the Bouvé College of Health Sciences' School of Pharmacy.
"We are developing state-of-the art applications multiplexing cell cycle and cell motility. The HoloMonitor platform offers unique 4-dimensional imaging capabilities that greatly enhance our understanding of both functions, which was previously unachievable by other technologies," added Ed Luther, supervisor of Northeastern's Core Imaging and Cytometry facility.
"The agreement with Northeastern emphasizes our commitment to creating a network of scientists applying HoloMonitor technology in a growing number of biological research areas", said Peter Egelberg, CEO of PHI.
Founded in 1898, Northeastern University is a global, experiential, research university built on a tradition of engagement with the world, creating a distinctive approach to education and research. Based in Boston, with graduate campuses in Charlotte and Seattle, the university offers more than 90 undergraduate majors and a comprehensive range of graduate programs, from professional master's degrees to interdisciplinary doctoral programs. The university's research enterprise is designed to tackle some of the most pressing issues of our time including health, security and sustainability. Students participate in Northeastern's signature co-op program and other forms of experiential learning in 114 countries on all seven continents.
PHI is the leader in the development of ground-breaking holographic time-lapse cytometry instrumentation and software. The company offers a range of products for long-term quantitative analysis of cellular dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI is committed to promoting the science and practice of time-lapse cytometry through scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.
SOURCE Phase Holographic Imaging and Northeastern University